
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 1.5625 | 3.84 | 4.3 | 3.71 | 847320 | 3.9312353 | CS |
4 | 1.06 | 37.323943662 | 2.84 | 4.34 | 2.84 | 844571 | 3.6626131 | CS |
12 | 0.8 | 25.8064516129 | 3.1 | 4.34 | 1.865 | 1021124 | 2.94802634 | CS |
26 | -2 | -33.8983050847 | 5.9 | 6.13 | 1.865 | 1246723 | 3.88934595 | CS |
52 | -3.43 | -46.7939972715 | 7.33 | 11.4 | 1.865 | 1485932 | 6.30561477 | CS |
156 | 2.05 | 110.810810811 | 1.85 | 14.0435 | 1.79 | 874760 | 6.67439818 | CS |
260 | -13.05 | -76.9911504425 | 16.95 | 28.36 | 1.45 | 631349 | 6.92914366 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions